These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3655404)

  • 21. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
    Ray NB; Ewalt LC; Lodmell DL
    Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canine vaccine recipients recognize an immunodominant region of the rabies virus glycoprotein.
    Johnson N; Mansfield KL; Fooks AR
    J Gen Virol; 2002 Nov; 83(Pt 11):2663-2669. PubMed ID: 12388801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
    Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L
    J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine.
    Rupprecht CE; Wiktor TJ; Johnston DH; Hamir AN; Dietzschold B; Wunner WH; Glickman LT; Koprowski H
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7947-50. PubMed ID: 3464010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antigenic activity and the reactogenicity of a concentrated, purified, UV-inactivated cultured rabies vaccine].
    Dulina AV; Morogova VM; Shafeeva RS; Pogrebniak EM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):47-50. PubMed ID: 6637275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy of the ERA rabies vaccine, in mice against 4 antigenic variants of rabies virus].
    Erbolato EB; da Silva EV; Miguel O; Sureau P; Germano PM
    Rev Saude Publica; 1989 Dec; 23(6):447-54. PubMed ID: 2641836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of combined vaccines for rabies and immunocontraception.
    Wu X; Franka R; Svoboda P; Pohl J; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7202-9. PubMed ID: 19925954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
    Okoh AE; Umoh JU; Ezeokoli CD; Addo PB
    Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-protection of mice against a global spectrum of rabies virus variants.
    Lodmell DL; Smith JS; Esposito JJ; Ewalt LC
    J Virol; 1995 Aug; 69(8):4957-62. PubMed ID: 7609065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic variation of wild and vaccine rabies strains of Egypt.
    Botros BA; Salib AW; Mellick PW; Linn JM; Soliman AK; Scott RM
    J Med Virol; 1988 Feb; 24(2):153-9. PubMed ID: 3351484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations.
    Perrin P; Joffret ML; Oth D; Leclerc C; Sureau P; Thibodeau L
    Vaccine; 1988 Aug; 6(4):331-8. PubMed ID: 2461004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM
    Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
    Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus.
    Perrin P; Versmisse P; Delagneau JF; Lucas G; Rollin PE; Sureau P
    J Biol Stand; 1986 Apr; 14(2):95-102. PubMed ID: 3531213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.